COVID-19

Data from a recent survey reflect a resounding shift toward the role of pharmacies becoming sites for primary care.

Viral vector vaccines and a booster can protect maternal women against the Omicron variant of COVID-19, but the mRNA vaccine with a booster dose appears to offer the best protection.

Can the profession afford not to retain expanded job roles for technicians in a post-pandemic era?

The new strategy would propose annual COVID-19 vaccines, much like annual flu shots.

Antibodies help neutralize the virus, though the levels decrease at the 6-month mark, data indicate.

Educating patients, posting on social media, and countering misinformation are critical strategies.

18F-FDG PET/CT detects approximately 73% of tumor lesions, while 68Ga-FAPI finds approximately 94%.

Older patients received cancer treatment less frequently during the pandemic, as did patients covered by Medicaid.

Analysis indicates 4 peptides had significant or nearly significant seropositivity, all of which were associated with membrane and spike proteins of SARS-COVID-2.

COVID-19 infection was significantly associated with increased risks of several conditions, including loss of smell and taste, concentration, and memory impairment.

Recommendations vary based on age, first vaccination received, and time since the last dose.

Providers use "Kitchen Sink Approach" because cure proves elusive, symptomatic treatment is sketchy.

The risk of severe COVID-19 continues to outweigh the rare risk of post-vaccination myocarditis.

Relative risk calculations show that vaccinated individuals infected with the first Omicron subvariants of COVID-19 could have protection that lasts nearly 3 seasons.

An overview of current theses and research surrounding the pathogenesis, presentation, and treatment of COVID-19 in children.

Children who experienced COVID-19-induced multisystem inflammatory syndrome did not experience severe adverse reactions following COVID-19 vaccination.

Greater prevalence of hand eczema among health care professionals working in COVID-19 units linked to increased hand sanitation habits.

In addition to the physical symptoms of long COVID, patients have reported vocal, verbal, and cognitive issues that disrupt their ability to communicate.

Intravenous tocilizumab (Actemra; Genentech) has been approved for the treatment of COVID-19 in individuals who are hospitalized and receiving systemic corticosteroids and supplemental oxygen.

The analysis found that individuals in underserved communities were as much as 34% less likely to be vaccinated against COVID-19.

Pharmacists have been increasingly recognized as key partners in the clinical services needed to manage the pandemic.

Similar symptoms often make it difficult for patients to tell the contagious respiratory conditions apart.

There are limited data on the efficacy of boosters for preventing infection and death in nursing home residents, but the findings suggest that boosters may have significantly reduced COVID-19–associated morbidity and mortality in this population.

By leveraging do-it-yourself testing momentum, community-based and retail pharmacies can solidify their position as health care hubs with a category management approach that enhances the consumer experience and boosts store relevance and revenue.

When mildly ill, individuals who reflect on the potential consequences of their behavior are less likely to go to holiday gatherings and events.

Booster shots updated for the Omicron variant BA.4 and BA.5 lineages cleared for children 6 months through 4 years of age.

Pharmacy Times will be covering the 64th American Society of Hematology (ASH) Annual Meeting and Exposition, which gathers pharmacy professionals working in malignant and classical hematology in New Orleans, Louisiana.

Both vaccine hesitancy and antivax beliefs are largely fueled by inaccurate reports of adverse effects from vaccines, a new study finds.

Pharmacists concluded that the workflow could be implemented for any drugs that are in short supply.

Program provides a virtual assessment and treatment with buprenorphine, a medication for opioid cravings and withdrawal symptoms.